Brainstorm Cell Therapeutics Developing Parkinson's Treatment
Related News: Spinal / Nervous / BrainBrainstorm Cell Therapeutics is currently developing a new stem cell therapy specifically to treat Parkinson's Disease. The research includes using a patient's bone marrow stem cells to produce the missing chemical that enables restoration of motor movement.
This process has shown to successfully alleviated symptoms of Parkinson's in rats. It will further be tested on monkeys next year. If all goes as planned, human clinical trials are scheduled for the following year.
Tel Aviv, Israel - based BrainStorm uses adult stem cells to repair neurological damage. The methodology which was was developed at Tel Aviv University, is now the company's propriety technology, known as NurOwn. NurOwn has proven to be capable of generating neuron-like cells derived from human bone marrow. These cells produce dopamine which can them be implanted into the Parkinson's patients.
NurOwn was developed by Prof. Eldad Melamed, Head of Neurology of the Rabin Medical Center and member of the Michael J. Fox Foundation for Parkinson's Research, together with Tel Aviv University cell biologist Dr. Daniel Offen and Dr. Yosef Levy.
In June of 2004, BrainStorm acquired the exclusive worldwide rights to commercialize NurOwn technology through a licensing agreement with Ramot, the technology transfer company of TAU...
Posted on March 31, 2005 12:13 PM